---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-25-000132"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:44:46.732823+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners Q2 revenue up 8.4% to $826.2M; Adj EBITDA $129M, up 9%; reaffirms FY2025 guidance

## Summary
- Revenue $826.2M (+8.4% YoY); same-facility revenue +5.1%, same-facility cases +3.4%.
- Adjusted EBITDA $129.0M (+9.0% YoY); net loss attributable to Surgery Partners $2.5M.
- Full-year 2025 guidance reaffirmed: revenue $3.30-3.45B, Adjusted EBITDA $555-565M.
- Cash $250.1M and $394.9M revolver capacity at June 30, 2025; net debt/EBITDA 4.1x.
- CEO cites active evaluation of portfolio optimization to reduce leverage and accelerate cash flow.

## SEC filing metadata
- accession: 0001638833-25-000132
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883325000132/0001638833-25-000132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883325000132/sgry-20250805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-25-000132
- JSON: https://secwatch.observer/filing/0001638833-25-000132.json
- Plain text: https://secwatch.observer/filing/0001638833-25-000132.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.